279 related articles for article (PubMed ID: 16997628)
1. Making a case for domperidone in the treatment of gastrointestinal motility disorders.
Ahmad N; Keith-Ferris J; Gooden E; Abell T
Curr Opin Pharmacol; 2006 Dec; 6(6):571-6. PubMed ID: 16997628
[TBL] [Abstract][Full Text] [Related]
2. Domperidone: a peripherally acting dopamine2-receptor antagonist.
Barone JA
Ann Pharmacother; 1999 Apr; 33(4):429-40. PubMed ID: 10332535
[TBL] [Abstract][Full Text] [Related]
3. Domperidone, a new dopamine antagonist.
Champion MC; Hartnett M; Yen M
CMAJ; 1986 Sep; 135(5):457-61. PubMed ID: 3527396
[TBL] [Abstract][Full Text] [Related]
4. Domperidone: review of pharmacology and clinical applications in gastroenterology.
Reddymasu SC; Soykan I; McCallum RW
Am J Gastroenterol; 2007 Sep; 102(9):2036-45. PubMed ID: 17488253
[TBL] [Abstract][Full Text] [Related]
5. [Pharmacologic and clinical differentiation of prokinetic drugs].
May B; Greving I
Leber Magen Darm; 1996 Jul; 26(4):193-8. PubMed ID: 8965601
[TBL] [Abstract][Full Text] [Related]
6. The dual role of domperidone in gastroparesis and lactation.
Phan H; DeReese A; Day AJ; Carvalho M
Int J Pharm Compd; 2014; 18(3):203-7. PubMed ID: 25306766
[TBL] [Abstract][Full Text] [Related]
7. Clinical evaluation of domperidone in the treatment of chronic postprandial idiopathic upper gastrointestinal distress.
Nagler J; Miskovitz P
Am J Gastroenterol; 1981 Dec; 76(6):495-9. PubMed ID: 7036711
[TBL] [Abstract][Full Text] [Related]
8. Modulation of gastrointestinal motility beyond metoclopramide and domperidone : Pharmacological and clinical evidence for phytotherapy in functional gastrointestinal disorders.
Madisch A; Vinson BR; Abdel-Aziz H; Kelber O; Nieber K; Kraft K; Storr M
Wien Med Wochenschr; 2017 May; 167(7-8):160-168. PubMed ID: 28424994
[TBL] [Abstract][Full Text] [Related]
9. [Kinetic drug Motilium: pharmacological properties and potential clinical use].
Sheptulin AA
Klin Med (Mosk); 1997; 75(11):48-50. PubMed ID: 9490358
[No Abstract] [Full Text] [Related]
10. Randomized Controlled Clinical Trial on Value of Domperidone in Functional Abdominal Pain in Children.
Karunanayake A; Devanarayana NM; de Silva A; Gunawardena S; Rajindrajith S
J Pediatr Gastroenterol Nutr; 2018 May; 66(5):725-731. PubMed ID: 29112086
[TBL] [Abstract][Full Text] [Related]
11. Promotility medications--now and in the future.
Karamanolis G; Tack J
Dig Dis; 2006; 24(3-4):297-307. PubMed ID: 16849857
[TBL] [Abstract][Full Text] [Related]
12. Dosage and drug interactions of domperidone.
Robinson P
Am J Gastroenterol; 2008 Apr; 103(4):1049. PubMed ID: 18397438
[No Abstract] [Full Text] [Related]
13. Dopamine antagonists in the upper gastrointestinal tract.
Valenzuela JE; Dooley CP
Scand J Gastroenterol Suppl; 1984; 96():127-36. PubMed ID: 6382574
[TBL] [Abstract][Full Text] [Related]
14. Domperidone in Parkinson's disease: a perilous arrhythmogenic or the gold standard?
Lertxundi U; Domingo-Echaburu S; Soraluce A; García M; Ruiz-Osante B; Aguirre C
Curr Drug Saf; 2013 Feb; 8(1):63-8. PubMed ID: 23656449
[TBL] [Abstract][Full Text] [Related]
15. Drugs in Focus: Domperidone.
Puoti MG; Assa A; Benninga M; Broekaert IJ; Carpi FJM; Deganello Saccomani M; Dolinsek J; Homan M; Mas E; Miele E; Tzivinikos C; Thomson M; Borrelli O
J Pediatr Gastroenterol Nutr; 2023 Aug; 77(2):e13-e22. PubMed ID: 37159421
[TBL] [Abstract][Full Text] [Related]
16. [Use of the prokinetic domperidine in patients in the early postoperative period].
Aleksseva EV; Fominykh VP; Tropskaia NS; Popova TS
Khirurgiia (Mosk); 2010; (3):62-9. PubMed ID: 20517269
[TBL] [Abstract][Full Text] [Related]
17. Moving ahead or falling behind?
Hanauer SB
Nat Clin Pract Gastroenterol Hepatol; 2007 Jun; 4(6):295. PubMed ID: 17541443
[No Abstract] [Full Text] [Related]
18. Dopaminergic modulation of rectosigmoid motility: action of domperidone.
Wiley J; Owyang C
J Pharmacol Exp Ther; 1987 Aug; 242(2):548-51. PubMed ID: 3612550
[TBL] [Abstract][Full Text] [Related]
19. [Effect of a new gastrokinetic drug on gastrointestinal motility: domperidone, a peripheral antidopaminergic drug].
Chevrel B
Med Chir Dig; 1981; 10(2):175-8. PubMed ID: 7230953
[No Abstract] [Full Text] [Related]
20. Domperidone: limited benefits with significant risk for sudden cardiac death.
Hondeghem LM
J Cardiovasc Pharmacol; 2013 Mar; 61(3):218-25. PubMed ID: 23188128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
